BiotechTube
August Bioservices

August Bioservices

Nashville, United States· Est.
augustbio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $28M

Overview

August Bioservices is an innovative CDMO headquartered in Nashville, TN, focused exclusively on sterile injectables. The company offers a fully integrated portfolio of capabilities, including product development, analytical services, and advanced manufacturing, designed to support clients from early-phase clinical trials to commercial supply. With a leadership team boasting decades of collective experience in aseptic manufacturing and a commitment to quality and collaboration, August Bio aims to be an indispensable partner in bringing life-altering therapies to patients faster.

BiologicsContract Manufacturing

Technology Platform

August Bioservices provides an integrated CDMO service platform for sterile injectables, encompassing process development, analytical testing, and advanced aseptic manufacturing using state-of-the-art flexible filling lines and single-use technology.

Funding History

2
Total raised:$28M
Series A$23M
Seed$5M

Opportunities

The company is positioned to capitalize on the robust growth in biologics and complex injectable drug development, where outsourcing is standard.
Its US-based, integrated model offers a compelling value proposition for biotechs seeking speed, quality, and regulatory assurance.
Expansion into adjacent service areas like aseptic manufacturing for advanced therapies (e.g., cell & gene) represents a significant future opportunity.

Risk Factors

Key risks include high dependence on winning and retaining client projects in a competitive CDMO market, the capital-intensive nature of maintaining state-of-the-art aseptic facilities, and significant regulatory exposure where any compliance failure could severely impact operations and reputation.

Competitive Landscape

August Bioservices competes with large, diversified CDMOs (e.g., Catalent, Lonza) and specialized injectable manufacturers. Its differentiation lies in its exclusive focus on sterile injectables, a collaborative partnership approach, and advanced, flexible manufacturing technology housed in a single, integrated US site, aiming to reduce complexity for clients.

More companies in Drug Delivery & Formulation →More companies in United States →